United States - English - NLM (National Library of Medicine)

health masters llc - fucus vesiculosus (unii: 535g2abx9m) (fucus vesiculosus - unii:535g2abx9m), potassium carbonate (unii: bqn1b9b9ha) (carbonate ion - unii:7ujq5ope7d), agave americana leaf (unii: 8511zmp5qk) (agave americana leaf - unii:8511zmp5qk), capsicum (unii: 00uk7646fg) (capsicum - unii:00uk7646fg), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell ca - for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress. for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress.

United States - English - NLM (National Library of Medicine)

health masters llc - echinacea angustifolia whole (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), arctium lappa root (unii: 597e9bi3z3) (arctium lappa root - unii:597e9bi3z3), solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), taraxacum officinale (unii: 39981fm375) (taraxacum officinale - unii:39981fm375), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), aloe (unii: v5vd430yw9) (aloe - unii:v5vd430yw9), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), mahonia aquifolium root bark (unii: vzj9f3c3sb) (berberis aquifolium root bark - unii:vzj9f3c3sb), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus whole (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3), glycyrrhiza glabra (unii: 2788z9758h) (glycyrrhiza glabra - unii:2788z9758h), centella asiatica (unii: 7m867g6t1u) (centella asiatica - unii:7m867g6t1u), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), iris versicolor root (unii: x43d4l3dqc) (iris versicolor root - unii:x43d4l3dqc), lachesis muta venom (unii: vsw71ss07i) (lachesis muta venom - unii:vsw71ss07i), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), toxicodendron pubescens leaf (unii: 6io182rp7a) (toxicodendron pubescens leaf - unii:6io182rp7a), ruta graveolens flowering top (unii: n94c2u587s) (ruta graveolens flowering top - unii:n94c2u587s), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), thyroid, bovine (unii: mn18otn73w) (thyroid, bovine - unii:mn18otn73w) - formulated for symptoms associated with low energy, fatigue and mild stress. formulated for symptoms associated with low energy, fatigue and mild stress.

United States - English - NLM (National Library of Medicine)

health masters llc - milk thistle (unii: u946sh95ee) (milk thistle - unii:u946sh95ee), cynara scolymus leaf (unii: b71ua545de) (cynara scolymus leaf - unii:b71ua545de), solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), taraxacum officinale (unii: 39981fm375) (taraxacum officinale - unii:39981fm375), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), centaurea benedicta (unii: 6l5zl09795) (centaurea benedicta - unii:6l5zl09795), ceanothus americanus leaf (unii: 25b1y14t8n) (ceanothus americanus leaf - unii:25b1y14t8n), chelidonium majus whole (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), chionanthus virginicus bark (unii: s9y4b22u2e) (chionanthus virginicus bark - unii:s9y4b22u2e), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), dioscorea villosa tuber (unii: iwy3iwx2g8) (dioscorea villosa root - unii:iwy3iwx2g8), mucuna pruriens fruit trichome (unii: 3e271bsi0c) (mucuna pruriens fruit trichome - unii:3e271bsi0c), iris versicolor root (unii: x43d4l3dqc) (iris versicolor root - unii:x43d4l3dqc), juniper berry (unii: o84b5194rl) (juniper berry - unii:o84b5194rl), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), ptelea trifoliata bark (unii: 5kqr6ftt0d) (ptelea trifoliata bark - unii:5kqr6ftt0d), uric acid (unii: 268b43mj25) (uric acid - unii:268b43mj25) - formulated for symptoms associated with liver, kidney and colon functions and for symptoms associated with toxic conditions. formulated for symptoms associated with liver, kidney and colon functions and for symptoms associated with toxic conditions.

United States - English - NLM (National Library of Medicine)

health masters llc - fucus vesiculosus (unii: 535g2abx9m) (fucus vesiculosus - unii:535g2abx9m), potassium carbonate (unii: bqn1b9b9ha) (carbonate ion - unii:7ujq5ope7d), ferula assa-foetida resin (unii: w9fza51as1) (asafetida - unii:w9fza51as1), capsicum (unii: 00uk7646fg) (capsicum - unii:00uk7646fg), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium - for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress. for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress.

Ireland - English - HPRA (Health Products Regulatory Authority)

global vet health sl - amoxicillin trihydrate - powder for use in drinking water - 500 milligram(s)/gram - amoxicillin - chickens, ducks, pigs, turkeys - antibacterial

United States - English - NLM (National Library of Medicine)

health mart - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb, carbonate ion - unii:7ujq5ope7d) - calcium carbonate 750 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 20 mg - tablet, uncoated - excipient ingredients: hypromellose; lactose monohydrate; iron oxide red; maleic acid; zinc stearate; iron oxide yellow; maize starch - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: hypromellose; maleic acid; iron oxide red; zinc stearate; maize starch; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maleic acid; zinc stearate; maize starch; hypromellose; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - lisinopril dihydrate, quantity: 21.78 mg (equivalent: lisinopril, qty 20 mg) - tablet, uncoated - excipient ingredients: maize starch; pregelatinised maize starch; iron oxide red; colloidal anhydrous silica; mannitol; magnesium stearate; calcium hydrogen phosphate dihydrate - hypertension. lisinopril generic health tablets are indicated in the treatment of hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents. sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. congestive heart failure lisinopril generic health tablets are also indicated in the treatment of heart failure. in such patients, it is recommended that lisinopril generic health tablets be administered together with a diuretic. acute myocardial infarction: lisinopril generic health tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmhg. lisinopril may be initiated within 24 hours of an acute myocardial infarction.